Bakhai Smita, Ahluwalia Gaurav, Nallapeta Naren, Mangat Amanpreet, Reynolds Jessica L
Department of Internal Medicine, University at Buffalo, The State University of New York, Buffalo, New York, USA.
Department of Medicine, University at Buffalo, The State University of New York, Buffalo, New York, USA.
BMJ Open Qual. 2018 Oct 25;7(4):e000400. doi: 10.1136/bmjoq-2018-000400. eCollection 2018.
Colorectal cancer (CRC) is the second leading cause of cancer death in USA, and CRC screening remains suboptimal. The aim of this quality improvement was to increase CRC screening in the internal medicine clinic (IMC) patients, between the ages of 50-75 years, from a baseline rate of 50%-70% over 12 months with the introduction of faecal immunochemical test (FIT) testing. We used the Plan-Do-Study-Act (PDSA) method and performed a root cause analysis to identify barriers to acceptance of CRC screening. The quality improvement team created a driver diagram to identify and prioritise change ideas. We developed a process flow map to optimise opportunities to improve CRC screening. We performed eight PDSA cycles. The major components of interventions included: (1) leveraging health information technology; (2) optimising team work, (3) education to patient, physicians and IMC staff, (4) use of patient navigator for tracking FIT completion and (5) interactive workshops for the staff and physicians to learn motivational interview techniques. The outcome measure included CRC screening rates with either FIT or colonoscopy. The process measures included FIT order and completion rates. Data were analysed using a statistical process control and run charts. Four hundred and seven patients visiting the IMC were offered FIT, and 252 (62%) completed the test. Twenty-two (8.7%) of patients were FIT positive, 14 of those (63.6%) underwent a subsequent diagnostic colonoscopy. We achieved 75% CRC screening with FIT or colonoscopy within 12 months and exceeded our goal. Successful strategies included engaging the leadership, the front-line staff and a highly effective multidisciplinary team. For average-risk patients, FIT was the preferred method of screening. We were able to sustain a CRC screening rate of 75% during the 6-month postproject period. Sustainable annual FIT is required for successful CRC screening.
结直肠癌(CRC)是美国癌症死亡的第二大主要原因,而CRC筛查仍未达到最佳水平。本质量改进项目的目的是,通过引入粪便免疫化学检测(FIT),在12个月内将内科门诊(IMC)50至75岁患者的CRC筛查率从基线水平的50%提高到70%。我们采用计划-实施-研究-改进(PDSA)方法,并进行根本原因分析,以确定接受CRC筛查的障碍。质量改进团队创建了一个驱动图,以识别并优先考虑变革想法。我们绘制了一个流程地图,以优化改善CRC筛查的机会。我们进行了8个PDSA循环。干预措施的主要组成部分包括:(1)利用健康信息技术;(2)优化团队协作;(3)对患者、医生和IMC工作人员进行教育;(4)使用患者导航员跟踪FIT完成情况;(5)为工作人员和医生举办互动研讨会,学习动机性访谈技巧。结果指标包括FIT或结肠镜检查的CRC筛查率。过程指标包括FIT的医嘱下达率和完成率。使用统计过程控制和运行图对数据进行分析。共有407名到IMC就诊的患者接受了FIT检测,其中252人(62%)完成了检测。22名(8.7%)患者FIT检测呈阳性,其中14人(63.6%)随后接受了诊断性结肠镜检查。我们在12个月内通过FIT或结肠镜检查实现了75%的CRC筛查率,超过了我们的目标。成功策略包括吸引领导层、一线工作人员和一个高效的多学科团队参与。对于平均风险患者,FIT是首选的筛查方法。在项目结束后的6个月内,我们能够将CRC筛查率维持在75%。成功的CRC筛查需要可持续的年度FIT检测。